Clinical Trial

Sleep Loss and Circadian Misalignment - Mechanisms of Insulin Resistance

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The purpose of this study is to examine the impact of timed cortisol release or differently timed cortisol rhythms on insulin resistance in both men and women undergoing sleep restriction. Chronic sleep loss is highly prevalent, affecting 1 in 3 adults in the US. Chronic sleep loss causes stress which induces insulin resistance and leads to obesity and type 2 diabetes. Many factors contribute to sleep loss including shift work, environmental disturbances, sleep/circadian disorders and comorbid medical and mental health conditions. Sleep loss increases the stress hormone cortisol in the evening and decreases daytime testosterone. Examining these hormones in a controlled laboratory environment under different sleep schedules may help researchers find solutions for adults experiencing negative health consequences related to chronic sleep loss.
Protocol Amendment History 3 changes
critical Primary endpoint(s) modified 2026-05-16
notable Enrollment increased: 24 -> 48 participants 2026-05-16
minor Trial arms changed: 2 -> 4 2026-05-16
Trial Details
NCT Number NCT07494084
Lead Sponsor Washington State University
Collaborators: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Conditions Shift Work Schedule, Circadian Rhythm, Insulin Resistance, Circadian Misalignment
Enrollment 48 participants
Start Date 2026-07-01
Primary Completion 2029-03 (estimated)
Study Completion 2029-07 (estimated)
Updated on ClinicalTrials.gov 2026-05-15